Analysis of tumor-infiltrating lymphocytes in HCC revealed that LAG-3 expression was upregulated in HBV-specific CD8+ T cells compared to the CD8+ T cells in the peripheral blood [129]. This evidence concerns the gene LAG3 and hepatocellular carcinoma.